Perry Haney, MD, is a member of the Board of SpineOne, based in Lone Tree, Colorado, a leading regional medical center for minimally invasive spine care.
Dr. Haney will participate in the panel “Big Ideas for Increasing Patient Volume Without Breaking the Budget” and “Big Trends in ASC Coding and Billing: Orthopedics, Spine” at the 19th Annual Becker Spine Conference, orthopedics and pain management. As part of an ongoing series, Becker’s speaks with healthcare leaders who plan to speak at the conference, which takes place in Chicago from June 16-18.
For more information and to register, click here.
Question: What issues do you spend the most time on today?
Dr. Perry Haney: Right now, we’re fine-tuning our revenue cycle. Most people have issues with managing the revenue cycle, mostly due to all the new requirements on insurance companies and just the mechanics of the EMR.
Q: What are your main challenges and how will they evolve over the next 12 months?
pH: I think over the next 12 months and probably the next three to five years there will be more and more intrusion from insurance companies and basically practicing medicine without a license, could I to add. I think trying to find ways to keep your repayments where they need to be so you can survive is key. Doctors and medical institutions are struggling to cope with rising costs, especially medical costs with [personal protective equipment]. We still don’t produce a lot of PPE in the United States or a lot of our medicine and medical supplies.
Q: How do you see investments and growth over the next two years?
pH: I now think I speak for SpineOne and Trinity Hunt Partners, but we are very interested in going big and growing and being a flagship platform for primarily minimally invasive spine care and pain management.
Q: What are you most excited about right now?
pH: We are truly excited to pursue these potential acquisitions with like-minded practices across the country. Plus, there are some really cool things about stem cells, especially their anti-inflammatory quality. If you get real stem cells and mesenchymal pluripotent stem cells, I think in the future it will be exciting because I think we’re going to be able to treat a lot of general orthopedic joint problems without surgery. Certainly there will always be surgery, but I think more and more it will be by injection and by the use of stem cells and in the spine.